Share
When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
Manage episode 523730971 series 2893730
Content provided by Saul Marquez. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Saul Marquez or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
The future of cancer care is shifting toward earlier detection, continuous monitoring, and truly personalized treatment powered by high-quality genomic insights.
In this episode, Ajay Gannerkote, President of Integrated DNA Technologies, explains how rapid advances in genomics are transforming cancer diagnosis, precision medicine, and personalized care. He describes how IDT evaluates emerging technologies by combining custom manufacturing, high-quality reagents, and deep scientific partnerships to deliver clinically meaningful insights. Ajay highlights how NGS, MRD, and multi-cancer detection are expected to accelerate over the next 3–5 years, enabling far earlier diagnosis and more precise monitoring. He also underscores the power of collaboration, shares a rare pediatric success story, and reflects on leadership principles centered on trust, innovation, and an “obligation to dissent.”
Tune in and learn how the next wave of genomic innovation is bringing precision medicine within reach for patients everywhere!
Resources
2139 episodes
))
